A Year After ‘Pivot To Growth’, Teva Keeps Pushing Forward With Innovative Assets

Firm Highlights LAI Olanzapine, As Trial Results Come Nine Months Ahead Of Schedule

Finger pushing innovation button
Another of Teva’s innovative assets has delivered results • Source: Shutterstock

More from Products

More from Generics Bulletin